VISEN Pharmaceuticals and Distinct HealthCare Announce Strategic Partnership to Accelerate Commercialization of Weizhenhigh® (Long-Acting Growth Hormone)
May 27, 2026 18:03
CST Updated
May 28, 14:34
VISEN
Endocrine-related Disease Treatment Drug Developer
Distinct HealthCare
High-Quality, Digital Medical Service Provider